the health care
When Drug Price Transparency Isn’t Enough
By KRISTINA SMITH & PHIYEN NGUYEN Policymakers and advocates often promote d…
By KRISTINA SMITH & PHIYEN NGUYEN Policymakers and advocates often promote drug price transparency to lower costs and improve equity. While transparency…
By KRISTINA SMITH & PHIYEN NGUYEN Policymakers and advocates often promote d…
I met the Nabla management team two years ago. Two years later they have ridden the wav…
By JEFF GOLDSMITH In mid-April 2025, UnitedHealth Group (UNH) reported its 1Q25 ope…
By KIM BELLARD These are, it must be said, grim times for American science. Between…
By KAYLA KELLY Every semester I have the privilege of guiding nursing students thro…
By JACOB REIDER & JODI DANIEL Jacob: I recently needed to sign a Business A…
What are the practices that we have normalized that future generations will criticize u…
By JEFF GOLDSMITH The health policy community is obsessed with hospital mergers. In…
Kai Romero is Head of Clinical Success at Evidently. The company is one of many that ar…
By KIM BELLARD In 2025, we’ve got DNA all figured out, right? It’s been over fifty…
By LEONARD D’AVOLIO I’m in the waiting room of the New England Baptist Hospital. Th…
By STEVEN ZECOLA Artificial intelligence (“AI”) has taken root in the field of drug…
By HOLLI BRADISH-LANE I’ve seen clients start GLP-1 medications full of hope—and st…
Our website uses cookies to improve your experience. Learn more